Left ventricular non-compaction (LVNC), also known as "spongy myocardium," is a rare congenital cardiomyopathy characterized by an abnormally thick, trabeculated left ventricular myocardium. Instead of the typical compact myocardial layer, LVNC presents with an excessive amount of trabeculations and intertrabecular recesses, giving it a sponge-like appearance. This structural abnormality can lead to a range of clinical manifestations, from asymptomatic findings to life-threatening arrhythmias and heart failure. While the precise etiology remains incompletely understood, genetic factors are strongly implicated, and the condition can be diagnosed at any age, though often in childhood or adolescence. This article will comprehensively explore LVNC, focusing on its diagnosis, clinical presentation, and most importantly, its treatment.
Background:
The development of the normal left ventricle involves a process of compaction, where the primitive myocardial trabeculae undergo programmed apoptosis and resorption, resulting in a compact, efficient pumping chamber. In LVNC, this process is disrupted, leading to the persistence of excessive trabeculation and intertrabecular spaces. These spaces are filled with blood during systole, reducing the effective contractile mass and compromising ventricular function. The resulting cardiomyopathy can manifest in various ways, depending on the severity of the non-compaction and the presence of associated complications.
LV Non-Compaction Criteria and Diagnosis:
Diagnosis of LVNC relies heavily on echocardiography, with specific criteria used to identify the characteristic features. Several scoring systems exist, though no single universally accepted standard is available. Generally, the diagnosis involves assessing the ratio of non-compacted to compacted myocardial thickness in the left ventricle. A ratio exceeding 2:1 in two or more segments during systole is frequently employed as a diagnostic criterion. However, this ratio can be influenced by factors such as age, loading conditions, and imaging technique, highlighting the importance of clinical correlation.
LV Non-Compaction on Echo:
Echocardiography remains the cornerstone of LVNC diagnosis. Transthoracic echocardiography (TTE) often provides the initial assessment, revealing the characteristic spongy appearance of the left ventricle. However, TTE may be limited by image quality, especially in obese patients or those with poor acoustic windows. Transesophageal echocardiography (TEE) can offer superior image resolution in such cases, providing a more detailed visualization of the left ventricular anatomy. Careful attention should be paid to assessing the left ventricular ejection fraction (LVEF), which can vary widely depending on the disease severity. Other echocardiographic findings may include mitral regurgitation, left atrial enlargement, and reduced global longitudinal strain.
Non-Compaction Cardiomyopathy Pictures:
Visualizing the characteristic features of LVNC is crucial for accurate diagnosis. Echocardiographic images, both still and cine-loops, are indispensable for demonstrating the excessive trabeculations and intertrabecular recesses. Cardiac magnetic resonance imaging (CMR) provides superior spatial resolution and allows for a more detailed assessment of myocardial thickness and function. CMR images can be used to confirm the echocardiographic findings and provide a more precise quantification of the non-compacted myocardium. These images, when coupled with clinical findings, are essential for establishing a definitive diagnosis.
Compaction vs Non-Compaction Cardiomyopathy:
current url：https://xexrbq.e351c.com/bag/lv-non-compaction-treatment-87224